Skip to content
Clinical Trials – home

Combined immunodeficiency Life with Disease

1 / 1 trials open to patients1 country

In short

Combined immunodeficiency represents a group of serious conditions where both major parts of the immune system fail to work properly, leaving the body vulnerable to infections that would normally be harmless. Understanding these disorders and their progression is essential for families navigating this challenging diagnosis.

Key points

  • Combined immunodeficiency affects both T cells and B cells, leaving the body unable to fight infections that healthy people easily overcome.
  • Early diagnosis through newborn screening has dramatically improved survival rates to over 90 percent when treatment begins before serious infections develop.
  • Without treatment, severe forms are usually fatal within the first two years of life, making this a pediatric emergency requiring immediate attention.
  • Bone marrow transplantation success rates have improved substantially, making it a viable option even for patients without perfectly matched sibling donors.
  • Many successful transplant recipients still require lifelong antibody infusions because while T cells engraft, B cells often do not.
  • Daily life requires extensive infection prevention measures including meticulous hand hygiene, mask wearing, and avoiding crowded or enclosed spaces.
  • The condition exists on a spectrum from mild to severe, and predicting outcomes for individual patients remains challenging even for experienced specialists.
  • Families face significant emotional, social, and financial burdens, but resources and support networks exist to help navigate this challenging journey.

Prognosis and Long-Term Outlook

The outlook for people with combined immunodeficiency varies significantly depending on several factors, including the specific genetic cause, how early the condition is diagnosed, and whether successful treatment can be started before serious infections develop. This variation in severity makes it difficult for doctors to predict exactly what will happen in each individual case, which can be especially challenging for families trying to understand what lies ahead.

Unlike the most severe form called severe combined immunodeficiency (SCID), where children typically do not survive past two years without treatment, combined immunodeficiency exists on a spectrum. Some forms cause mild to moderate disease, while others lead to severe susceptibility to infections along with inflammatory complications from a malfunctioning immune system. The immune system may be present but simply not work well, allowing the development of excessive reactions against the body's own tissues.

The good news is that treatment options have improved substantially over recent years. The success rate of hematopoietic stem cell transplantation (HSCT), which is essentially a bone marrow transplant, has gotten much better, particularly for patients who do not have a perfectly matched sibling donor. This means the risk of this treatment has become much more acceptable even for people with less severely affected immune systems. When SCID is diagnosed and treated within the first few months of life before serious infections develop, the long-term survival rate can be more than 90 percent.

Natural Progression Without Treatment

When combined immunodeficiency goes untreated, the disease typically reveals itself within the first two years of life through repeated infections and signs that the immune system is not functioning as it should. Children with this condition often present with recurrent infections that seem to come back again and again, along with problems related to immune dysregulation where the immune system attacks the body's own tissues instead of protecting it.

Because both T cells (white blood cells that identify and attack threats) and B cells (white blood cells that make protective proteins called antibodies) are affected, the body has no effective way to ward off infections. T cells not only directly attack cells infected with germs but also help B cells produce antibodies. When T cells are missing or not working properly, B cells cannot function either, leaving the person essentially defenseless.

Without a functioning immune system, a child faces constant risk from infections that healthy children easily fight off. These can include serious respiratory infections like pneumonia, intestinal infections causing chronic diarrhea that leads to weight loss and failure to thrive, and fungal infections like thrush in the mouth and on the skin. The child may also develop ear infections, sinus infections, skin rashes, and in severe cases, meningitis or blood infections that can spread throughout the body.

For individuals with milder forms of combined immunodeficiency, symptoms may not appear until later in childhood or even early adulthood. However, for those with more severe variants, particularly SCID, the situation is urgent. Without treatment, these children rarely survive beyond their first or second birthday, succumbing to overwhelming infections that their bodies simply cannot fight.

Possible Complications

Beyond the constant threat of infections, combined immunodeficiency can lead to several unexpected and serious complications that affect multiple body systems. The most concerning is that routine infections can quickly become life-threatening. What might cause a mild illness in a healthy person can progress rapidly to severe, invasive disease in someone with combined immunodeficiency.

One major complication is immune dysregulation, where the malfunctioning immune system begins attacking the body's own organs and tissues. This can result in autoimmune diseases where the body treats its own cells as enemies, leading to inflammation throughout the body. This excessive self-reactivity creates additional health problems on top of the infection susceptibility, making treatment more complex.

Chronic infections can damage organs over time. For example, repeated lung infections can lead to permanent lung damage and breathing difficulties. Persistent diarrhea from intestinal infections can cause severe malnutrition and problems absorbing nutrients from food, which is especially serious in growing children. The constant state of infection and inflammation puts enormous stress on a developing body.

Another complication involves treatments themselves. When stem cell transplantation is performed, there is a risk of graft versus host disease (GVHD), where the transplanted immune cells recognize the recipient's body as foreign and attack it. Additionally, in approximately 75 to 80 percent of combined immunodeficiency patients who have a successful bone marrow transplant, the success may be only partial. Their bodies accept the donor T cells but the B cells do not take hold, meaning these patients require lifelong infusions of protective antibodies called gamma globulin to prevent infections.

There is also increased risk for certain types of cancers in people with immunodeficiency disorders. When the immune system cannot properly patrol the body for abnormal cells, cancerous cells may grow unchecked. Additionally, treatments that suppress the immune system further, such as those used to control autoimmune complications, can increase infection risk even more.

Impact on Daily Life

Living with combined immunodeficiency affects virtually every aspect of daily life, from the most routine activities to long-term planning. For young children with this condition, normal childhood experiences like attending daycare, playing with other children, or visiting public places become fraught with danger because of potential exposure to germs. Families often need to create a carefully controlled environment to minimize infection risk while still allowing the child to develop and grow.

Physical limitations are significant. Children with combined immunodeficiency may struggle to gain weight and grow at a normal rate because chronic infections and inflammation consume so much of the body's energy. They may tire easily and lack the stamina that healthy children have for play and activities. Frequent medical appointments, treatments, and hospitalizations interrupt school and normal routines, making it difficult to maintain a sense of normalcy.

The emotional toll on both the child and family can be profound. Parents live with constant worry about their child's health and survival. They must become experts in infection prevention, learning to recognize early signs of illness, and making difficult decisions about their child's activities and social interactions. Siblings may feel neglected when so much attention must focus on the sick child. The affected child may feel isolated from peers and struggle with being different.

Social life becomes complicated. Simple activities that other families take for granted, like going to restaurants, attending birthday parties, or traveling, require extensive planning and risk assessment. During respiratory virus season, extra precautions become necessary. The family may need to avoid crowded places or ask visitors to stay away if they have any signs of illness, which can strain relationships with extended family and friends.

Work and school present unique challenges. Parents may need to reduce work hours or stop working entirely to provide constant care and attend frequent medical appointments. Children may miss significant amounts of school due to illness and medical treatments. When they can attend, special accommodations may be needed, and parents must educate teachers and school staff about the child's condition and needs.

Financial burdens can be overwhelming. Medical expenses add up quickly, including costs for frequent doctor visits, laboratory tests, medications, immunoglobulin replacement therapy, potential hospitalizations, and possibly stem cell transplantation. Even with insurance, families often face significant out-of-pocket expenses. The need for specialized care may require traveling to distant medical centers, adding travel and lodging costs.

Despite these challenges, many families find ways to adapt and create a fulfilling life. They develop routines that work for them, connect with other families facing similar challenges, and celebrate small victories. Children can still pursue hobbies and interests at home, maintain friendships through careful planning, and with successful treatment, may eventually lead relatively normal lives. Learning to balance necessary caution with allowing the child to have childhood experiences remains an ongoing challenge that families navigate day by day.

Support for Families Considering Clinical Trials

Clinical trials represent an important avenue for advancing treatment options for combined immunodeficiency, and families should understand how they might participate in research that could benefit their child and others in the future. Clinical trials are carefully designed research studies that test new treatments, medications, or approaches to care. They are conducted under strict safety guidelines to protect participants while gathering important information.

Families considering clinical trials should know that participation is always voluntary. No one should feel pressured to enroll, and you can withdraw at any time without affecting your child's regular medical care. It is essential to have thorough conversations with the research team to understand what the trial involves, what the potential benefits and risks are, and how it differs from standard treatment. Ask questions until you feel confident you understand everything.

Finding appropriate clinical trials can feel overwhelming, but resources exist to help. The Immune Deficiency Foundation and other organizations maintain databases of clinical trials specifically for primary immunodeficiency disorders. Your child's medical team can also help identify trials that might be suitable based on the specific type of combined immunodeficiency and current health status. Research centers that specialize in immunodeficiency disorders often conduct multiple trials and can discuss options with you.

Relatives and caregivers play a crucial role in the clinical trial process. Your primary responsibility is to serve as an advocate for your child, making sure their needs and wellbeing remain the top priority. This means thoroughly researching any trial being considered, asking detailed questions about what will happen, how it might help or harm your child, and what additional time commitments and travel it might require. You are the expert on your child, and your observations and input are valuable to the research team.

Practical support matters tremendously. If you decide to participate in a trial, you may need to help with additional monitoring, record-keeping, or administering treatments at home. You will need to transport your child to more frequent appointments and possibly travel to distant research centers. Planning for childcare for siblings, taking time off work, and managing the logistics of participation all require family support and coordination.

Emotional support is equally important. Clinical trials can feel uncertain and stressful. Your child may not understand why they need extra tests or procedures. Family members can help by maintaining routines as much as possible, providing comfort and reassurance, celebrating the contribution you are making to science, and connecting with other families who have participated in trials. Many research programs have patient navigators or coordinators who can offer additional support and answer questions throughout the process.

Understanding the informed consent process is vital. This is more than just signing paperwork. It involves detailed discussions about the trial's purpose, procedures, potential risks and benefits, alternatives, and your rights as a participant. Take time to read all materials carefully, discuss them with trusted advisors including your regular doctors, and make sure both parents or guardians understand and agree before proceeding. Remember that consenting to a trial does not mean you cannot change your mind later if circumstances change.

Finally, families should know that participating in clinical trials contributes to the broader understanding of combined immunodeficiency and helps develop better treatments for future generations. While the primary consideration should always be what is best for your child right now, knowing that participation may help other families facing this diagnosis can provide additional meaning during a difficult journey. Research has already led to dramatic improvements in survival rates, and ongoing studies continue to push forward our understanding and treatment capabilities.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Elapegademase – A replacement enzyme used for treating adenosine deaminase (ADA) deficiency, which is one form of combined immunodeficiency. It helps replace the missing enzyme needed for proper lymphocyte development and immune function.
  • Immunoglobulin (Ig) replacement therapy – Intravenous or subcutaneous administration of antibodies to help protect patients who cannot produce sufficient antibodies on their own, providing passive immunity against infections.

Did you know?

  1. Severe combined immunodeficiency became widely known through the story of David Vetter, the "bubble boy," who lived in a germ-free plastic bubble for 12 years in the 1970s and 80s, which led to increased awareness and research funding for these conditions.
  2. Thanks to newborn screening programs now available in all 50 U.S. states, most babies with severe forms of combined immunodeficiency are diagnosed before they develop serious health problems, dramatically improving survival rates to over 90 percent when treated early.
  3. In approximately 75 to 80 percent of successful bone marrow transplants for combined immunodeficiency, only the T cells successfully engraft while B cells do not, requiring patients to receive lifelong antibody infusions to prevent infections.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Combined immunodeficiency

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Transduced With A Lentiviral Vector Containing The Human Dclre1C Gene
  • Sponsor:Assistance Publique Hopitaux De Paris
See all 1 trials →filters applied: condition = Combined immunodeficiency

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).